3D vs 2D HD Laparoscopy in Cholecystectomy
- Conditions
- Cholecystolithiasis
- Interventions
- Procedure: 2D laparoscopic cholecystectomyProcedure: 3D laparoscopic cholecystectomy
- Registration Number
- NCT02357589
- Lead Sponsor
- Helsinki University Central Hospital
- Brief Summary
The 3D-systems have emerged also to the world of surgery, and the three-dimensional laparoscopic systems are gradually entering the operating rooms. In the normal laparoscopy there are only two-dimensional view, which is somewhat challenging when operating in three-dimensional environment. Even though the 3D-systems have been widely studied in laboratory circumstances, there are still no evidence of benefits of 3D vs 2D in clinical point of view and no prospective randomized trials have been published. Therefore, the purpose of this study is to investigate is there something to gain in changing into 3D laparoscopic system for cholecystectomy (LCC).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 210
- Patients scheduled for laparoscopic cholecystectomy
- Some other surgical operation planned during LCC
- Expected major risk of conversion (e.g. multiple previous abdominal operation, previous peritonitis, previous cholecystitis)
- Operating surgeon experience less than 5 3D laparoscopy operations
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 2D laparoscopic cholecystectomy 2D laparoscopic cholecystectomy The normal laparoscopic cholecystectomy with two dimensional view 3D laparoscopic cholecystectomy 3D laparoscopic cholecystectomy The normal laparoscopic cholecystectomy with three dimensional view
- Primary Outcome Measures
Name Time Method Duration of surgery Expected average time of surgery 1 hour
- Secondary Outcome Measures
Name Time Method Intraoperative complications During the operation, expected average time of surgery 1 hour Any complication during the operation e.g. hemorrhagic, liver, intestine or gallbladder rupture
Complications, Clavien-Dindo classification 30 days after randomization Postoperative stay in hospital Expected range 0-7 day Bleeding During the operation, expected average time of surgery 1 hour Mortality 30 days after randomization Need for conversion into open surgery During the operation, expected average time of surgery 1 hour Total need of opioids in milligrams Expected range 0-7 day Operation theatre time Expected average 1,5 hours Number of participants with readmission(s) 30 days after randomization Postoperative pain, VAS Expected range 0-7 day
Trial Locations
- Locations (1)
Helsinki University Central Hospital
🇫🇮Helsinki, Finland